Tumor priming by SMO inhibition enhances antibody delivery and efficacy in a pancreatic ductal adenocarcinoma model
Published date:
07/30/2019
Excerpt:
In contrast, murine Gli1 expression was abundant, and all PDX tumors responded to 40 and 80 mg/kg/day NVP-LDE225 with time-dependent Gli1 suppression (Fig. 1B, S2B, S3).